BIOS Fund II NT, LP

CIK 1728851 · last filed 2025-06-13

BIOS Fund II NT, LP is a corporate insider who has filed 7 SEC Form 4 insider transactions across 2 companies since 2023. The most recent filing shows the insider sold $1.2M of LTRN on Jun 13, 2025. Across all open-market trades the lifetime net is −$8.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $106.9K across reported positions. The firm reports its address in Fort Worth, TX. 31 SEC filings were submitted jointly with BIOS Fund II, LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$106.9K

Companies

2

Total Filings

7

Lifetime Open-Market Net

-$8.71M

Filer Profile

Reported Address
1401 FOCH STREET, SUITE 140
FORT WORTH, TX 76107
Phone
(817) 984-5964
State of Incorporation
DE
Related Filers
BIOS Fund II, LP — 31 joint filings, latest 2025-06-30
BIOS Fund II QP, LP — 30 joint filings, latest 2025-06-30
Bios Equity Partners II, LP — 24 joint filings, latest 2025-06-30
BIOS Fund I QP, LP — 20 joint filings, latest 2025-06-30
BIOS Fund I, LP — 20 joint filings, latest 2025-06-30
Cavu Advisors, LLC — 20 joint filings, latest 2025-06-30
Cavu Management, LP — 20 joint filings, latest 2025-06-30
Leslie W. Kreis — 19 joint filings, latest 2025-06-30
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LTRN 10%+ Owner 49,957 $1.71 $85.4K -$8.71M 3 2025-06-13
INAB 10%+ Owner 20,066 $1.07 $21.5K $0 1 2023-12-14

Recent Filings

7 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-06-13 LTRN Sell (S) −400,000 -$1.24M EDGAR
2025-05-27 LTRN Notice (144) −25,849 -$85.0K EDGAR
2024-04-26 LTRN Notice (144) −54,597 -$291.5K EDGAR
2024-02-28 LTRN Notice (144) −13,417 -$52.5K EDGAR
2024-01-19 LTRN Mixed +201,320 $19 EDGAR
2023-12-14 INAB Buy (P) $0 EDGAR
2023-12-01 LTRN Sell (S) −1,453,480 -$5.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.